Hideki Takeshita

Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study

2023 | Lékařská fakulta v Plzni, Lékařská fakulta v Hradci Králové

Publikace